Find uplifting stories about heroes, innovations, and solutions
2774 results for "** pancreatic cancer"
A new pill targeting the KRAS mutation doubles survival time in pancreatic cancer patients, marking the biggest treatment breakthrough ever for one of the world's deadliest cancers. After 25 years of research and $17 million in funding, scientists are finally seeing progress on multiple fronts at once.
A daily pill called daraxonrasib helped control cancer in 90% of pancreatic cancer patients during early trials, offering new hope for a disease that has had few effective treatments. The drug targets genetic mutations found in over 90% of pancreatic cancers.
A breakthrough drug called daraxonrasib doubled survival time for pancreatic cancer patients compared to chemotherapy, offering new hope for one of the deadliest cancers. The treatment targets the genetic mutation behind 90% of pancreatic cancers and causes far fewer severe side effects.
Scientists in Spain eliminated pancreatic tumors in mice using a triple-drug therapy, with no cancer returning over 200 days. The breakthrough targets the deadliest form of pancreatic cancer and could reshape treatment if human trials succeed.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. --- ##
A breakthrough drug for pancreatic cancer has stunned researchers by controlling disease in 90% of patients who had already tried chemotherapy. The daily pill targets gene mutations found in nearly all pancreatic cancers, offering hope where treatment options have been scarce.
Scientists in Ireland have created the first complete "playbook" of pancreatic cancer, revealing why it's been so deadly and where new treatments could finally work. Their breakthrough approach targets multiple weak points at once, offering fresh hope for a disease that has resisted progress for decades.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
An experimental pill called daraxonrasib helped pancreatic cancer patients live nearly twice as long as those on standard chemotherapy. The breakthrough results, presented at a major cancer conference, mark a historic first for one of medicine's toughest cancers.
Scientists at Oregon Health & Science University just cracked a puzzle that's stumped cancer researchers for years: why pancreatic cancer fights off immunotherapy. The discovery could finally give patients new treatment options.
University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
Researchers discovered that pancreatic cancer cells depend on inflammation from damaged mitochondria to survive, and blocking this process kills tumors. The breakthrough could finally offer new treatment options for one of the deadliest cancers.
For the first time in three decades, patients with inoperable pancreatic cancer have a new treatment option. The FDA just approved Optune Pax, a wearable device you use at home that uses electric fields to kill cancer cells.
The FDA just approved Optune Pax, a new treatment option for people battling locally advanced pancreatic cancer. This approval brings fresh hope to patients facing one of the most challenging cancer diagnoses.
A new once-daily pill for pancreatic cancer nearly doubled patient survival in a groundbreaking late-stage study. The experimental drug offers fresh hope for one of the deadliest forms of cancer.
For the first time in years, doctors have a promising new weapon against one of the deadliest cancers. A targeted therapy that blocks specific gene mutations is bringing fresh hope to pancreatic cancer patients and their families.
A new treatment called daraxonrasib has shown remarkable results for advanced pancreatic cancer patients, nearly doubling their survival time in clinical trials. The breakthrough offers fresh hope for one of the deadliest forms of cancer.
A revolutionary drug just doubled survival time for patients with advanced pancreatic cancer, one of the deadliest forms of the disease. Doctors are calling it unprecedented, and the breakthrough could soon help patients with lung, colorectal, and other cancers too.
A new pill for pancreatic cancer helped patients live nearly twice as long as standard chemotherapy in a groundbreaking study. The experimental drug could bring hope to one of the deadliest cancers within months.
A breakthrough treatment for pancreatic cancer shows promise in doubling how long patients survive with one of the deadliest forms of cancer. This medical advance offers new hope for thousands of families facing this devastating diagnosis.
Showing 20 of 2774